Indeed, phosphatase inhibitors and isoform-specific antibodies against CD45 have been developed, but these have only been tested in the context of leukemia, organ transplantation, or IgE-mediated anaphylaxis [79,80,81,82]. Here, PTPRC is linked to leukemia.